Market Overview:
The global endovascular therapy device market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in endovascular devices, and rising demand for minimally invasive procedures. Based on type, the global endovascular therapy device market is segmented into aortic stents, biodegradable stents, self-expanding nitinol stents, and others. The aortic stent segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for these devices across regions. Based on application, the global endovascular therapy device market is divided into hospitals, clinics, and ambulatory surgery centres (ASCs).
Product Definition:
An endovascular therapy device is a medical device used to treat various conditions or diseases by accessing the inside of the body through blood vessels. These devices can include stents, balloons, and other tools used to fix or remove blockages.
Aortic Stents:
Aortic stents are used to treat aortic stenosis, which is the most common type of bifurcation disease. The prevalence of aortic stenosis is estimated to be around 1% in western countries and 5-10% in developing countries. The treatment for this condition has evolved over time with various technological advancements such as endovascular stent grafts, bioabsorbable stents, and drug-eluting stents.
Biodegradable Stents:
Biodegradable stents are used in endovascular therapy devices market to prop open blood vessels during the treatment of diseases such as aneurysms, carotid blockage, and stroke. The biodegradable nature of these stents makes them a preferred choice over metal or drug-eluting stents.
Application Insights:
Based on application, the global endovascular therapy device market is segmented into hospitals, clinics and ambulatory surgery centers. Hospitals dominated the overall market in terms of revenue share in 2017. This can be attributed to a large patient base that requires cardiovascular intervention as well as an increasing number of hospital-based ECT procedures. In addition, rising awareness about better treatment options for various diseases such as stroke and heart attack is expected to boost the demand for these devices over the forecast period.
The clinic segment held a significant share in 2017 owing to an increasing number of outpatient procedures being performed with regard to cardiovascular diseases along with growing investments by private players towards R&D pertaining endovascular therapies for conditions such as atherosclerosis and coronary artery disease among others.
Regional Analysis:
North America dominated the global endovascular therapy device market in 2016 with a revenue share of over 40%. The growth can be attributed to factors such as favorable reimbursement policies, high healthcare expenditure, and increasing prevalence of cardiovascular diseases. Europe is expected to witness significant growth during the forecast period due to growing target population base and rising incidence of CVDs. Asia Pacific region is anticipated to grow at a lucrative rate during the forecast period owing to improving healthcare infrastructure, increasing patient awareness levels about various treatment options available for CVDs & hypertension, rising disposable income coupled with government initiatives for quality medical care delivery system.
Key players operating in this industry are Boston Scientific Corporation; Medtronic plc.
Growth Factors:
- Increasing incidence of vascular diseases: The global prevalence of vascular diseases is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. Endovascular therapy devices are increasingly becoming the preferred treatment option for these conditions as they offer several advantages over traditional open surgery.
- Technological advancements: The endovascular therapy device market is witnessing rapid technological advancements, with new products and devices being launched regularly. This is helping to improve patient outcomes and increase adoption rates among healthcare professionals.
- Growing demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures across the world as they offer several benefits over traditional surgery, such as reduced pain, shorter hospital stays, and faster recovery times. Endovascular therapy devices are ideally suited for use in minimally invasive procedures and are thus expected to witness high growth rates in this segment in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Endovascular Therapy Device Market Research Report
By Type
Aortic Stents, Biodegradable Stents, Self-expanding Nitinol Stents, Others
By Application
Hospitals, Clinic, Ambulatory Surgery Centre
By Companies
Cardinal Health, Lombard Medical Technologies, Lifetech Scientific, Boston Scientific, Endospan, Getinge, InspireMD, Japan Lifeline, Endologix, Medtronic, Penumbra, Terumo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Endovascular Therapy Device Market Report Segments:
The global Endovascular Therapy Device market is segmented on the basis of:
Types
Aortic Stents, Biodegradable Stents, Self-expanding Nitinol Stents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Ambulatory Surgery Centre
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cardinal Health
- Lombard Medical Technologies
- Lifetech Scientific
- Boston Scientific
- Endospan
- Getinge
- InspireMD
- Japan Lifeline
- Endologix
- Medtronic
- Penumbra
- Terumo
Highlights of The Endovascular Therapy Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aortic Stents
- Biodegradable Stents
- Self-expanding Nitinol Stents
- Others
- By Application:
- Hospitals
- Clinic
- Ambulatory Surgery Centre
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endovascular Therapy Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endovascular therapy devices are medical devices that are inserted into the body through a vein to treat conditions. They can include stents, catheters, and balloons.
Some of the major players in the endovascular therapy device market are Cardinal Health, Lombard Medical Technologies, Lifetech Scientific, Boston Scientific, Endospan, Getinge, InspireMD, Japan Lifeline, Endologix, Medtronic, Penumbra, Terumo.
The endovascular therapy device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endovascular Therapy Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endovascular Therapy Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endovascular Therapy Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endovascular Therapy Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endovascular Therapy Device Market Size & Forecast, 2020-2028
4.5.1 Endovascular Therapy Device Market Size and Y-o-Y Growth
4.5.2 Endovascular Therapy Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Aortic Stents
5.2.2 Biodegradable Stents
5.2.3 Self-expanding Nitinol Stents
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Ambulatory Surgery Centre
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endovascular Therapy Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endovascular Therapy Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Aortic Stents
9.6.2 Biodegradable Stents
9.6.3 Self-expanding Nitinol Stents
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Ambulatory Surgery Centre
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Aortic Stents
10.6.2 Biodegradable Stents
10.6.3 Self-expanding Nitinol Stents
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Ambulatory Surgery Centre
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Aortic Stents
11.6.2 Biodegradable Stents
11.6.3 Self-expanding Nitinol Stents
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Ambulatory Surgery Centre
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Aortic Stents
12.6.2 Biodegradable Stents
12.6.3 Self-expanding Nitinol Stents
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Ambulatory Surgery Centre
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Aortic Stents
13.6.2 Biodegradable Stents
13.6.3 Self-expanding Nitinol Stents
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Ambulatory Surgery Centre
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endovascular Therapy Device Market: Competitive Dashboard
14.2 Global Endovascular Therapy Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cardinal Health
14.3.2 Lombard Medical Technologies
14.3.3 Lifetech Scientific
14.3.4 Boston Scientific
14.3.5 Endospan
14.3.6 Getinge
14.3.7 InspireMD
14.3.8 Japan Lifeline
14.3.9 Endologix
14.3.10 Medtronic
14.3.11 Penumbra
14.3.12 Terumo
